Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2015

Dec 10, 2015

29745_dirs_2015-12-10_4d22f76a-4d0c-45e5-ab62-5291632ed513.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-12-09

Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-09 Common Stock S 25000 $83.88 Disposed 88131 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4792 Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $83.66 to $84.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.